Business
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the development of a 5.5 mL version of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe. This innovation is designed to be fully compatible with Ypsomed's YpsoMate® 5.5 autoinjector platform, expanding options for pharmaceutical companies and patients who require large‑volume subcutaneous self‑injections.
About this update from Becton, Dickinson And Company
[{"type":"text","content":"The enhanced collaboration and innovation will improve options for pharmaceutical companies and patients requiring large-volume self-injection systems","length":150,"tagName":"p","attribs":{}},{"type":"text","content":"LE PONT-DE-CLAIX, France and BURGDORF, Switzerland, Jan. 21, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the development of a 5.5 mL version of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe. This innovation is designed to be fully compatible with Ypsomed's YpsoMate® 5.5 autoinjector platform, expanding options for pharmaceutical companies and patients who require large‑volume subcutaneous self‑injections.","length":600,"tagName":"p"},{"type":"image","alt":"In development BD Neopak(TM) XtraFlow(TM) 5.5mL Glass Prefillable Syringe","displaySize":"","headline":null,"caption":"In development BD Neopak(TM) XtraFlow(TM) 5.5mL Glass Prefillable Syringe","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":300,"url":"https://media.zenfs.com/en/prnewswire.com/12543ce887a59b4ce0960c4a5982b223"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QlggnnDDyKQhoguHo4cXXw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTUyOTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/12543ce887a59b4ce0960c4a5982b223","width":400,"height":300}},"href":"https://mma.prnewswire.com/media/2865697/BD_Neopak.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Meeting the Needs of Today and Tomorrow's Biologics","length":55,"tagName":"p"},{"type":"text","content":"The new 5.5mL BD Neopak™ XtraFlow™ Glass Prefillable Syringe leverages BD advanced technologies, including a shorter, 8-millimeter needle and thinner wall cannulas, to support the delivery of higher volume and viscosity medicines. These enhancements should enable improved injection time and optimized flow, addressing common challenges with large-volume biologics and enabling drug developers to move beyond the limitations of standard syringe offerings.","length":455,"tagName":"p"},{"type":"text","content":""This next generation syringe is a direct response to the growing demand for patient-friendly solutions in the high-dose biologics space," said...